These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8997779)

  • 21. Violence from young women involuntarily admitted for severe drug abuse.
    Palmstierna T; Olsson D
    Acta Psychiatr Scand; 2007 Jan; 115(1):66-72. PubMed ID: 17201868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes for women with co-occurring disorders and trauma: program and person-level effects.
    Morrissey JP; Ellis AR; Gatz M; Amaro H; Reed BG; Savage A; Finkelstein N; Mazelis R; Brown V; Jackson EW; Banks S
    J Subst Abuse Treat; 2005 Mar; 28(2):121-33. PubMed ID: 15780541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Traditional and other drug use(r) intervention: necessary critical parameters.
    Einstein S
    Subst Use Misuse; 2007; 42(2-3):447-63. PubMed ID: 17558942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding relapse in the broader context of post-treatment functioning.
    Connors GJ; Maisto SA; Zywiak WH
    Addiction; 1996 Dec; 91 Suppl():S173-89. PubMed ID: 8997791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of 2-year drinking outcomes in a Swedish treatment sample.
    Bodin MC; Romelsjö A
    Eur Addict Res; 2007; 13(3):136-43. PubMed ID: 17570909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive validity of Marlatt's relapse taxonomy versus a more general relapse code.
    Stout RL; Longabaugh R; Rubin A
    Addiction; 1996 Dec; 91 Suppl():S99-110. PubMed ID: 8997784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do trauma history and PTSD symptoms influence addiction relapse context?
    Norman SB; Tate SR; Anderson KG; Brown SA
    Drug Alcohol Depend; 2007 Sep; 90(1):89-96. PubMed ID: 17459611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construct validation analyses on the Marlatt typology of relapse precipitants.
    Maisto SA; Connors GJ; Zywiak WH
    Addiction; 1996 Dec; 91 Suppl():S89-97. PubMed ID: 8997783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The outcome of treatment. Overview.
    Huebner RB; Fuller RK
    Recent Dev Alcohol; 2001; 15():301-5. PubMed ID: 11449750
    [No Abstract]   [Full Text] [Related]  

  • 30. Anxiety and substance use: layers of complexity.
    Castle DJ
    Expert Rev Neurother; 2008 Mar; 8(3):493-501. PubMed ID: 18345977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up.
    Dawson DA; Goldstein RB; Grant BF
    Alcohol Clin Exp Res; 2007 Dec; 31(12):2036-45. PubMed ID: 18034696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polysubstance abuse in liver transplant patients and its impact on survival outcome.
    Nickels M; Jain A; Sharma R; Orloff M; Tsoulfas G; Kashyap R; Bozorgzadeh A
    Exp Clin Transplant; 2007 Dec; 5(2):680-5. PubMed ID: 18194121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Looking forward and back to relapse: implications for research and practice.
    Connors GJ; Longabaugh R; Miller WR
    Addiction; 1996 Dec; 91 Suppl():S191-6. PubMed ID: 8997792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Women, Co-occurring Disorders, and Violence Study: a case for trauma-informed care.
    Clark HW; Power AK
    J Subst Abuse Treat; 2005 Mar; 28(2):145-6. PubMed ID: 15780543
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of an outcome prediction measure for alcoholism therapy by multimodal monitoring of treatment processes.
    Krampe H; Stawicki S; Ribbe K; Wagner T; Bartels C; Kroener-Herwig B; Ehrenreich H
    J Psychiatr Res; 2008 Nov; 43(1):30-47. PubMed ID: 18342335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Tridimensional Personality Questionnaire as a predictor of relapse in detoxified alcohol dependents. The European Fluvoxamine in Alcoholism Study Group.
    Meszaros K; Lenzinger E; Hornik K; Füreder T; Willinger U; Fischer G; Schönbeck G; Aschauer HN
    Alcohol Clin Exp Res; 1999 Mar; 23(3):483-6. PubMed ID: 10195822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in relapse situations.
    Rubin A; Stout RL; Longabaugh R
    Addiction; 1996 Dec; 91 Suppl():S111-20. PubMed ID: 8997785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The drug dependence syndrome concept as an organizing principle in the explanation and prediction of relapse.
    Babor TF; Cooney NL; Lauerman RJ
    NIDA Res Monogr; 1986; 72():20-35. PubMed ID: 3099208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.